Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Milestone Pharmaceuticals Inc. (MIST) had Income from Continuous Operations of $-17.41M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-17.41M |
|
-- |
|
-- |
|
$18.80M |
|
$-18.80M |
|
$-0.15M |
|
$-17.41M |
|
$-17.41M |
|
$-17.41M |
|
|
Income from Continuous Operations |
$-17.41M |
$-17.41M |
|
$-17.41M |
|
$-17.26M |
|
$-18.77M |
|
83.88M |
|
83.88M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$111.92M |
|
$0.51M |
|
$1.64M |
|
$113.56M |
|
$13.98M |
|
$57.19M |
|
$57.81M |
|
$71.79M |
|
$41.77M |
|
$41.77M |
|
$41.77M |
|
106.24M |
|
| Cash Flow Statement Financials | |
$-49.04M |
|
$11.25M |
|
$85.53M |
|
$25.31M |
|
$73.05M |
|
$47.73M |
|
$7.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.01 |
|
-- |
|
-- |
|
0.58 |
|
1.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-41.68% |
|
-41.68% |
|
-15.33% |
|
-17.59% |
|
$0.39 |
|
$-0.59 |
|
$-0.58 |
|